...
首页> 外文期刊>Journal of minimally invasive gynecology >Misdiagnosis of Leiomyosarcoma after Radiofrequency Ablation of Uterine Myomas
【24h】

Misdiagnosis of Leiomyosarcoma after Radiofrequency Ablation of Uterine Myomas

机译:子宫肌瘤射频消融后Leiomyosarcoma的误诊

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Minimally invasive therapies to treat symptoms of uterine myomas can be effective alternatives to major surgery. Such modalities include pharmacologic agents, uterine artery embolization, magnetic resonance-guided focused ultrasound, and laparoscopic radiofrequency ablation, known as the Acessa procedure. Acessa is used to treat women with symptomatic myomas and was approved by the US Food and Drug Administration in 2012. This case describes a patient who underwent Acessa and subsequently required hysterectomy for refractory symptoms. Pathology of her tumor was initially classified as epithelioid leiomyosarcoma but on subsequent review was classified as benign. This report highlights the challenges of accurate histologic diagnosis in the setting of using new therapeutic modalities. Clinicians should report such interventions to pathologists at the time of surgery to allow for accurate diagnosis. (C) 2019 Published by Elsevier Inc. on behalf of AAGL.
机译:微创疗法治疗子宫肌瘤的症状可以是主要手术的有效替代品。 这种方式包括药理剂,子宫动脉栓塞,磁共振引导的超声波和腹腔镜射频消融,称为弧度过程。 acessa用于治疗患有症状MyOMA的妇女,并于2012年被美国食品和药物管理局批准。本案描述了患者接受抗髋关节和随后需要难治性症状的子宫切除术。 她的肿瘤的病理学最初被归类为上皮内肌肉肉瘤,但随后的审查被归类为良性。 本报告突出了在使用新的治疗方式的设置中精确组织学诊断的挑战。 临床医生应在手术时向病理学家报告这种干预措施,以便准确诊断。 (c)2019年由elsevier公司发布代表AAGL。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号